NO20051987L - Behandling av soppinfeksjoner. - Google Patents

Behandling av soppinfeksjoner.

Info

Publication number
NO20051987L
NO20051987L NO20051987A NO20051987A NO20051987L NO 20051987 L NO20051987 L NO 20051987L NO 20051987 A NO20051987 A NO 20051987A NO 20051987 A NO20051987 A NO 20051987A NO 20051987 L NO20051987 L NO 20051987L
Authority
NO
Norway
Prior art keywords
treatment
posaconazole
fungal infections
medicament
prevention
Prior art date
Application number
NO20051987A
Other languages
English (en)
Inventor
Rachel Courtney
Mark A Laughlin
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20051987L publication Critical patent/NO20051987L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Anvendelse av posakonazol for fremstillingen av et medikament for behandlingen eller forebyggingen av soppinfeksjoner hos mermesker som er 12 år gamle eller eldre og som har behov for slik behandling eller forebygging, der medikamentet omfatter en effektiv mengde av posakonazol i oppdelte doser to til fire ganger daghg for å oppnå en aritmetisk midlere steady-state-gj ermomsnittsplasmakonsentiasj on av posakonazol på minst 300 ng/ml til minst omtient 550 ng/mg blir tilkjermegjort.
NO20051987A 2002-09-23 2005-04-22 Behandling av soppinfeksjoner. NO20051987L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41298502P 2002-09-23 2002-09-23
PCT/US2003/029762 WO2004026303A2 (en) 2002-09-23 2003-09-19 Use of posaconazole for the treatment of fungal infections

Publications (1)

Publication Number Publication Date
NO20051987L true NO20051987L (no) 2005-04-22

Family

ID=32030948

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051987A NO20051987L (no) 2002-09-23 2005-04-22 Behandling av soppinfeksjoner.

Country Status (11)

Country Link
US (1) US20040058974A1 (no)
EP (1) EP1542681A2 (no)
JP (1) JP2006503839A (no)
CN (1) CN1688306A (no)
AU (1) AU2003282806A1 (no)
BR (1) BR0314763A (no)
CA (1) CA2499897A1 (no)
MX (1) MXPA05003124A (no)
NO (1) NO20051987L (no)
WO (1) WO2004026303A2 (no)
ZA (1) ZA200502374B (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7406092B2 (en) * 2003-07-21 2008-07-29 Qlogic, Corporation Programmable pseudo virtual lanes for fibre channel systems
GB0409077D0 (en) * 2004-04-23 2004-05-26 Neutec Pharma Plc Treatment of fungal infections
US20060009469A1 (en) * 2004-05-28 2006-01-12 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmacutical compositions of posaconazole
US20060160823A1 (en) * 2004-05-28 2006-07-20 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmaceutical compositions of Posaconazole
CA2576589C (en) 2004-08-13 2013-11-12 Schering-Plough Ltd. Pharmaceutical formulation comprising an antibiotic, a triazole and a corticosteroid
CN101495096A (zh) 2006-05-30 2009-07-29 伊兰制药国际有限公司 纳米微粒泊沙康唑制剂
WO2010036427A1 (en) 2008-06-17 2010-04-01 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
KR20140063616A (ko) 2011-07-20 2014-05-27 브라이엄 영 유니버시티 소수성 세라게닌 화합물 및 이를 포함하는 기구
US9603859B2 (en) 2011-09-13 2017-03-28 Brigham Young University Methods and products for increasing the rate of healing of tissue wounds
US9694019B2 (en) 2011-09-13 2017-07-04 Brigham Young University Compositions and methods for treating bone diseases and broken bones
EP3449900A1 (en) 2011-12-21 2019-03-06 Brigham Young University Oral care compositions
US9533063B1 (en) 2012-03-01 2017-01-03 Brigham Young University Aerosols incorporating ceragenin compounds and methods of use thereof
CA2872399C (en) 2012-05-02 2021-01-12 Brigham Young University Ceragenin particulate materials and methods for making same
CN102755628B (zh) * 2012-07-16 2013-10-23 中国科学院微生物研究所 一种抗真菌的药物组合物
CA2888259C (en) 2012-10-17 2019-05-28 Brigham Young University Treatment and prevention of mastitis
AU2014203882B2 (en) 2013-01-07 2016-06-23 Brigham Young University Methods for reducing cellular proliferation and treating certain diseases
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US10568893B2 (en) 2013-03-15 2020-02-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
BR112015023747B1 (pt) 2013-03-15 2023-04-18 Brigham Young University Uso de um composto antimicrobiano catiônico esteroide (csa) para a preparação de uma composição para tratar, reduzir, ou prevenir inflamação aguda ou crônica e/ou dor aguda ou crônica associada com uma doença ou um sintoma de doença
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
CA2844321C (en) 2014-02-27 2021-03-16 Brigham Young University Cationic steroidal antimicrobial compounds
US9867836B2 (en) 2014-03-13 2018-01-16 Brigham Young University Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US9931350B2 (en) 2014-03-14 2018-04-03 Brigham Young University Anti-infective and osteogenic compositions and methods of use
US9686966B2 (en) 2014-04-30 2017-06-27 Brigham Young University Methods and apparatus for cleaning or disinfecting a water delivery system
US10441595B2 (en) 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
US10227376B2 (en) 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
US10155788B2 (en) 2014-10-07 2018-12-18 Brigham Young University Cationic steroidal antimicrobial prodrug compositions and uses thereof
US10370403B2 (en) 2015-04-22 2019-08-06 Brigham Young University Methods for the synthesis of ceragenins
US9527883B2 (en) 2015-04-22 2016-12-27 Brigham Young University Methods for the synthesis of ceragenins
US9434759B1 (en) 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity
US12186328B2 (en) 2019-05-23 2025-01-07 Brigham Young University Use of CSA compounds to stimulate stem cells and hair growth

Also Published As

Publication number Publication date
BR0314763A (pt) 2005-07-26
CA2499897A1 (en) 2004-04-01
WO2004026303A2 (en) 2004-04-01
WO2004026303A3 (en) 2004-04-29
AU2003282806A1 (en) 2004-04-08
EP1542681A2 (en) 2005-06-22
ZA200502374B (en) 2006-12-27
US20040058974A1 (en) 2004-03-25
CN1688306A (zh) 2005-10-26
MXPA05003124A (es) 2005-06-22
JP2006503839A (ja) 2006-02-02

Similar Documents

Publication Publication Date Title
Nayak et al. Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma
WO2004026303A3 (en) Use of posaconazole for the treatment of fungal infections
WO2021207409A3 (en) Small molecule inhibitors of sars-cov-2 viral replication and uses thereof
BR0314943A (pt) Inibidores da proteìna reguladora da condutância transmembrana da fibrose cìstica e usos destes
AR043188A1 (es) Metodos y composiciones para el tratamiento de enfermedades y trastornos asociados con niveles elevados de citoquinas proinflamatorias
NO20025601D0 (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
CR9842A (es) Composiciones de celecoxib
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
CY1116463T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
BRPI0515600A (pt) formas farmacêuticas opióides tendo cmédia e auc em estado estável proporcionais à dose e cmax de dose única inferior ao proporcional à dose
AR040709A1 (es) Formulacion de lamotrigina de liberacion prolongada y uso de la misma para su preparacion
NO20076245L (no) Anvendelse av TFPI for a behandle alvorlige bakterieinfeksjoner
EA200201276A1 (ru) Производные арилметиламина для использования в качестве ингибиторов триптазы
BR0213292A (pt) tratamento de pneumonia severa por administração de inibidor da via de fator tecidual (tfpi)
DE60108489D1 (de) Kombinationstherapien mit gefässschädigender aktivität
HUP9901360A2 (hu) Cimicifuga racemosa-ból származó extraktum alkalmazása
BRPI0414305A (pt) sistema de liberação de drogas por via oral
UY26422A1 (es) Método para administrar un inhibidor de fosfodiesterasa 4
ATE464052T1 (de) Neue pharmazeutische verwendungen von staurosporin-derivaten
PT1414467E (pt) Tratamento topico da mastalgia
BR0310061A (pt) Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
Mao et al. Modulating oxidative stress: A reliable strategy for coping with community-acquired pneumonia in older adults
NO20073575L (no) Farmasoytiske sammensetninger for behandling av cellulitt
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
SE0102887D0 (sv) New formulation